ReviewCancer management and research2024

Clinical Insights on Brexucabtagene Autoleucel for the Treatment of Patients with Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia.

Noam E Kopmar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.